Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ENPP4 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of ENPP4 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ENPP4 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ENPP4 mRNA and [Estradiol co-treated with TGFB1 protein] results in decreased expression of ENPP4 mRNA | CTD | PMID:20660070 and PMID:30165855 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ENPP4 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ENPP4 mRNA | CTD | PMID:17101203 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ENPP4 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ENPP4 mRNA | CTD | PMID:32109520 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Enpp4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ENPP4 mRNA | CTD | PMID:21570461 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ENPP4 mRNA | CTD | PMID:26251327 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ENPP4 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of ENPP4 mRNA | CTD | PMID:31881176 | aflatoxin M1 | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of ENPP4 mRNA | CTD | PMID:30928695 | antirheumatic drug | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of ENPP4 mRNA | CTD | PMID:24449571 | Aroclor 1254 | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of ENPP4 mRNA | CTD | PMID:23650126 | benzo[a]pyrene | increases methylation | ISO | ENPP4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ENPP4 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | ENPP4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ENPP4 5' UTR | CTD | PMID:27901495 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ENPP4 mRNA | CTD | PMID:26496021 | bisphenol A | increases methylation | ISO | ENPP4 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of ENPP4 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Enpp4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ENPP4 mRNA | CTD | PMID:30951980 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ENPP4 mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ENPP4 mRNA | CTD | PMID:25181051 | butanal | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of ENPP4 mRNA | CTD | PMID:26079696 | chlorpyrifos | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ENPP4 mRNA | CTD | PMID:37019170 | cisplatin | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ENPP4 mRNA | CTD | PMID:27392435 | clothianidin | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | clothianidin results in increased expression of ENPP4 mRNA | CTD | PMID:29044138 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of ENPP4 mRNA | CTD | PMID:26577399 and PMID:27523638 | cyclosporin A | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ENPP4 mRNA | CTD | PMID:20106945 | dorsomorphin | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ENPP4 mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | entinostat results in increased expression of ENPP4 mRNA | CTD | PMID:27188386 | fenthion | increases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Fenthion results in increased expression of ENPP4 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of ENPP4 mRNA] | CTD | PMID:22206623 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of ENPP4 mRNA | CTD | PMID:26194646 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ENPP4 mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ENPP4 mRNA | CTD | PMID:36331819 | methidathion | increases expression | ISO | Enpp4 (Mus musculus) | 6480464 | methidathion results in increased expression of ENPP4 mRNA | CTD | PMID:34813904 | methylmercury chloride | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ENPP4 mRNA | CTD | PMID:23179753 more ... | nickel sulfate | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ENPP4 mRNA | CTD | PMID:22714537 | paracetamol | affects expression | ISO | Enpp4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ENPP4 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ENPP4 mRNA | CTD | PMID:33387578 | pentachlorophenol | increases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of ENPP4 mRNA | CTD | PMID:23892564 | pentanal | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | pentanal results in increased expression of ENPP4 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ENPP4 mRNA | CTD | PMID:27153767 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ENPP4 mRNA more ... | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of ENPP4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENPP4 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | Enpp4 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ENPP4 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | Enpp4 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ENPP4 mRNA | CTD | PMID:18301758 | potassium chromate | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of ENPP4 mRNA | CTD | PMID:22714537 | progesterone | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of ENPP4 mRNA | CTD | PMID:20660070 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ENPP4 mRNA | CTD | PMID:19228061 | SB 431542 | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Silver results in decreased expression of ENPP4 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | Silver results in decreased expression of ENPP4 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ENPP4 mRNA | CTD | PMID:34032870 | sodium arsenite | decreases expression | ISO | Enpp4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ENPP4 mRNA | CTD | PMID:37682722 | temozolomide | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ENPP4 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ENPP4 mRNA | CTD | PMID:23411599 and PMID:34492290 | trichostatin A | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ENPP4 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | ISO | ENPP4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENPP4 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ENPP4 mRNA | CTD | PMID:24935251 and PMID:26272509 | valproic acid | affects expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ENPP4 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ENPP4 mRNA | CTD | PMID:23179753 more ... | vorinostat | increases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | vorinostat results in increased expression of ENPP4 mRNA | CTD | PMID:27188386 | zinc atom | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ENPP4 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | ENPP4 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of ENPP4 mRNA | CTD | PMID:22171008 | |